The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma

被引:19
|
作者
Sharma, Neeraj [1 ]
Smadbeck, James B. [2 ]
Abdallah, Nadine [3 ]
Zepeda-Mendoza, Cinthya [4 ]
Binder, Moritz [3 ]
Pearce, Kathryn E. [1 ]
Asmann, Yan W. [5 ]
Peterson, Jess F. [1 ,6 ]
Ketterling, Rhett P. [1 ,6 ]
Greipp, Patricia T. [1 ,6 ]
Bergsagel, P. Leif [7 ]
Rajkumar, S. Vincent [3 ]
Kumar, Shaji K. [3 ]
Baughn, Linda B. [1 ,6 ]
机构
[1] Mayo Clin, Div Lab Genet, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Computat Biol, Dept Quantitat Hlth Sci, Rochester, MN 55905 USA
[3] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA
[4] ARUP Labs, Cytogenet & Genom Microarray Lab, Salt Lake City, UT USA
[5] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Jacksonville, FL 32224 USA
[6] Mayo Clin, Div Hematopathol, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[7] Mayo Clin, Div Hematopathol, Dept Internal Med, Scottsdale, AZ USA
关键词
C-MYC; REARRANGEMENTS; LYMPHOMA; ABNORMALITIES; PROGRESSION; ACTIVATION; ONCOGENE; SURVIVAL; IMPACT;
D O I
10.1158/1078-0432.CCR-21-0005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Structural variants (SV) of the MYC gene region are common in multiple myeloma and influence disease progression. However, the prognostic significance of different MYC SVs in multiple myeloma has not been clearly established. Experimental Design: We conducted a retrospective study of multiple myeloma comparing MYC SV subtypes identified by next-generation sequencing (NGS) and FISH to MYC expression and disease survival using 140 cases from Mayo Clinic and 658 cases from the MMRF CoMMpass study. Results: MYC SVs were found in 41% of cases and were classified into nine subtypes. A correlation between the presence of a MYCSV and increased MYC expression was identified. Among the nine MYC subtypes, the non-immunoglobulin (non-Ig) insertion subtype was independently associated with improved outcomes, while the Ig insertion subtype, specifically involving the IgL gene partner, was independently associated with poorer outcomes compared with other MYC SV subtypes. Although the FISH methodology failed to detect approximately 70% of all MYC SVs, those detected by FISH were associated with elevated MYC gene expression and poor outcomes suggesting a different pathogenic role for FISH-detected MYC subtypes compared with other MYC subtypes. Conclusions: Understanding the impact of different MYC SVs on disease outcome is necessary for the reliable interpretation of MYC SVs in multiple myeloma. NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the multiple myeloma clone.
引用
收藏
页码:5430 / 5439
页数:10
相关论文
共 50 条
  • [21] Multiple myeloma in younger patients: the role of age as prognostic factor
    Corso, A
    Klersy, C
    Lazzarino, M
    Bernasconi, C
    ANNALS OF HEMATOLOGY, 1998, 76 (02) : 67 - 72
  • [22] MicroRNA in Multiple Myeloma-A Role in Pathogenesis and Prognostic Significance
    Pula, Anna
    Robak, Pawel
    Robak, Tadeusz
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (33) : 6753 - 6772
  • [23] Clinical and prognostic role of annexinA2 in multiple myeloma
    Seckinger, Anja
    Meissner, Tobias
    Moreaux, Jerome
    Depeweg, Daniela
    Hillengass, Jens
    Hose, Katja
    Reme, Thierry
    Roesen-Wolff, Angela
    Jauch, Anna
    Schnettler, Reinhard
    Ewerbeck, Volker
    Goldschmidt, Hartmut
    Klein, Bernard
    Hose, Dirk
    BLOOD, 2012, 120 (05) : 1087 - 1094
  • [24] Multiple myeloma in younger patients: the role of age as prognostic factor
    A. Corso
    C. Klersy
    M. Lazzarino
    C. Bernasconi
    Annals of Hematology, 1998, 76 : 67 - 72
  • [25] The Prognostic Role of Lactate Dehydrogenase at First Relapse of Multiple Myeloma
    Lee, Holly
    Jimenez-Zepeda, Victor H.
    ACTA HAEMATOLOGICA, 2020, 143 (06) : 516 - 517
  • [26] Association of Genetic Variants with FISH-Based Karyotyping Status in Multiple Myeloma Patients
    Johnson, D. C.
    Ross, F. M.
    Dickens, N. J.
    Davies, F. E.
    Child, J. A.
    Durie, B.
    Van Ness, B.
    Morgan, G. J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S132 - S133
  • [27] Cytogenetics in multiple myeloma (MM): the prognostic role of primary and secondary events
    Wenger, S.
    Pantic, M.
    Ihorst, G.
    Moller, M. D.
    Gutjahr, N.
    Frank, B.
    Dreyling, E.
    Jung, J.
    Greil, C.
    Wasch, R.
    Engelhardt, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 246 - 246
  • [28] Role of lncRNAs as prognostic factor and potential therapeutic target in Multiple Myeloma
    Carrasco-Leon, Arantxa
    Ezponda, Teresa
    Meydan, Cem
    Valcarcel, Luis Vitores
    Ordonez, Raquel
    Kulis, Marta
    Garate, Leire
    Miranda, Estibaliz
    Segura, Victor
    Guruceaga, Elisabeth
    Vilas-Zornoza, Amaia
    Alignani, Diego
    Castro-Labrador, Laura
    Pascual, Marien
    Amundarain, Ane
    El Omri, Halima
    Taba, Ruba Y.
    Calasanz, Maria-Jose
    Planes, Francisco
    Paiva, Bruno
    Mason, Christopher E.
    San-Miguel, Jesus
    Martin-Subero, Jose I.
    Melnick, Ari
    Agirre, Xabier
    Prosper, Felipe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E354 - E355
  • [29] The prognostic role of rare SNPs in receptor tyrosine kinases in multiple myeloma
    Keppler, S.
    Pischimarov, J.
    Knop, S.
    Langer, C.
    Weissbach, S.
    Ihne, S. M.
    Bargou, R. C.
    Einsele, H.
    Rosenwald, A.
    Stuehmer, T.
    Leich, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 184 - 185
  • [30] Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis
    Soekojo, Cinnie Yentia
    Wang, Guo-miao
    Chen, Yunxin
    Casan, Joshua
    Wolyncewicz, Grace
    Lin, Adeline
    Poon, Li Mei
    de Mel, Sanjay
    Koh, Liang Piu
    Tan, Lip Kun
    Ooi, Melissa G.
    Nagarajan, Chandramouli
    Liu, Yang
    Lai, Yue-yun
    Hu, Xiao-Jun
    Spencer, Andrew
    Gopalakrishnan, Sathish Kumar
    Lu, Jin
    Chng, Wee Joo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (08): : E470 - E477